One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Contrast-Induced Acute Kidney Injury and Cardiovascular Imaging: Danger or Distraction?.
Davenport, Matthew S. MD; Perazella, Mark A. MD; Nallamothu, Brahmajee K. MD
doi : 10.1161/CIRCULATIONAHA.122.062783
Volume 147(11) pgs. 847-923,e657-e673 March 14, 2023
Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks.
Desai, Milind Y. MD, MBA; Owens, Anjali MD; Geske, Jeffrey B. MD; Wolski, Kathy MPH; Saberi, Sara MD, MS; Wang, Andrew MD; Sherrid, Mark MD; Cremer, Paul C. MD, MS; Naidu, Srihari S. MD; Smedira, Nicholas G. MD, MBA; Schaff, Hartzell MD; McErlean, Ellen RN, MSN; Sewell, Christina RN; Balasubramanyam, Aarthi; Lampl, Kathy MD; Sehnert, Amy J. MD; Nissen, Steven E. MD
doi : 10.1161/CIRCULATIONAHA.122.062534
Septal reduction therapy (SRT) in patients with intractable symptoms from obstructive hypertrophic cardiomyopathy (oHCM) is associated with variable morbidity and mortality.
Can Novel Myosin Inhibitors Defer Septal Reduction Therapy in HCM? At What Risk and at What Cost?.
Rakowski, Harry MD; Bataiosu, Roxana MD
Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis.
Yonker, Lael M. MD ,,,*; Swank, Zoe PhD ,,*; Bartsch, Yannic C. PhD ,,*; Burns, Madeleine D. MS; Kane, Abigail MD; Boribong, Brittany P. PhD; Davis, Jameson P. BS; Loiselle, Maggie BS; Novak, Tanya PhD; Senussi, Yasmeen MBBS; Cheng, Chi-An PhD; Burgess, Eleanor MS; Edlow, Andrea G. MD; Chou, Janet MD; Dionne, Audrey MD; Balaguru, Duraisamy MD; Lahoud-Rahme, Manuella MD; Arditi, Moshe MD; Julg, Boris MD, PhD; Randolph, Adrienne G. MD; Alter, Galit PhD; Fasano, Alessio MD ,,,+; Walt, David R. PhD ,,,+
doi : 10.1161/CIRCULATIONAHA.122.061025
Cases of adolescents and young adults developing myocarditis after vaccination with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-targeted mRNA vaccines have been reported globally, but the underlying immunoprofiles of these individuals have not been described in detail.
Shedding Light on Mechanisms of Myocarditis With COVID-19 mRNA Vaccines.
Bozkurt, Biykem MD, PhD
In Vivo Dissection of Chamber-Selective Enhancers Reveals Estrogen-Related Receptor as a Regulator of Ventricular Cardiomyocyte Identity.
Cao, Yangpo PhD ,*; Zhang, Xiaoran MS ,*; Akerberg, Brynn N. PhD ,*; Yuan, Haiyun MD, PhD; Sakamoto, Tomoya PhD; Xiao, Feng PhD; VanDusen, Nathan J. PhD; Zhou, Pingzhu PhD; Sweat, Mason E. PhD; Wang, Yi PhD; Prondzynski, Maksymilian PhD; Chen, Jian PhD; Zhang, Yan PhD; Wang, Peizhe PhD; Kelly, Daniel P. MD; Pu, William T. MD
doi : 10.1161/CIRCULATIONAHA.122.061955
Cardiac chamber-selective transcriptional programs underpin the structural and functional differences between atrial and ventricular cardiomyocytes (aCMs and vCMs).
Pharmacology and Clinical Development of Factor XI Inhibitors.
Greco, Antonio MD; Laudani, Claudio MD; Spagnolo, Marco MD; Agnello, Federica MD; Faro, Denise Cristiana MD; Finocchiaro, Simone MD; Legnazzi, Marco MD; Mauro, Maria Sara MD; Mazzone, Placido Maria MD; Occhipinti, Giovanni MD; Rochira, Carla MD; Scalia, Lorenzo MD; Capodanno, Davide MD, PhD
doi : 10.1161/CIRCULATIONAHA.122.062353
AB Therapeutic anticoagulation is indicated for a variety of circumstances and conditions in several fields of medicine to prevent or treat venous and arterial thromboembolism.
Perm1 Protects the Heart From Pressure Overload-Induced Dysfunction by Promoting Oxidative Metabolism.
Tachibana, Shizuko PhD; Yu, Nam-Kyung PhD; Li, Ruixia MD; Fernandez-Costa, Carolina PhD; Liang, Alex BS; Choi, Janet BS; Jung, Dayoen BS; Xiao, Changchun PhD; Kralli, Anastasia PhD; Yates, John R. III PhD; Ross, Robert S. MD, MBA; Cho, Yoshitake PhD
Letter by Monzo and Melenovsky Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF".
Monzo, Luca MD, PhD; Melenovsky, Vojtech MD, PhD
Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF".
Selvaraj, Senthil MD, MS, MA; Kosiborod, Mikhail N. MD; Shah, Svati H. MD, MS; MHS
Anesthetic Care of the Pregnant Patient With Cardiovascular Disease: A Scientific Statement From the American Heart Association.
Meng, Marie-Louise MD, Chair; Arendt, Katherine W. MD; Banayan, Jennifer M. MD; Bradley, Elisa A. MD; Vaught, Arthur J. MD; Hameed, Afshan B. MD; Harris, Jade MSN, RN, C-OB, C-EFM; Bryner, Benjamin MD; Mehta, Laxmi S. MD, FAHA, Vice Chair; on behalf of the American Heart Association Council on Cardiovascular Surgery and Anesthesia; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; and Council on Peripheral Vascular Disease
doi : 10.1161/CIR.0000000000001121
AB The pregnancy-related mortality rate in the United States is excessively high. The American Heart Association is dedicated to fighting heart disease and recognizes that cardiovascular disease, preexisting or acquired during pregnancy, is the leading cause of maternal mortality in the United States. Comprehensive scientific statements from cardiology and obstetrics experts guide the treatment of cardio-obstetric patients before, during, and after pregnancy.
